RD
RedHill Biopharma Ltd.
RDHL · NASDAQ
$0.55 -2.69% (-$0.02)
1M -9.14%
Market Cap $1.73M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.73
32.8% upside
Trenutna cena
$0.55
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica RDHL trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/B 0.40x
P/S 0.18x
EV/FFO N/A
Growth
0 /100
Declining Rev. growth 83.34%
Book val. growth N/A
EPS growth N/A
Profitability
20 /100
Weak Op. margin 110.40%
Gross margin 64.45%
FCF margin 85.98%
Quality
7 /100
Poor Asset turnover 0.38x
ROIC 167.51%
ROA 36.74%
Debt
46 /100
Moderate Int. coverage -7.99x
Debt/Equity 0.25x
Current ratio 0.34x
Stability
1 /100
Unstable EPS volatility 126.53%
Beta 4.95x
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o RDHL
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Dror Ben-Asher
Employees
13
Headquarters
Tel Aviv
Prihajajoči dogodki
18 MAR.
Earnings
Upcoming earnings report